Meghan Scanlon
About Meghan Scanlon
Meghan Scanlon is the President of the Urology Division at Boston Scientific and a Board Member at Paragon 28, with a strong background in the medical device industry and a commitment to diversity and inclusion.
Company
Meghan Scanlon is currently serving as the President of the Urology Division at Boston Scientific. She joined Boston Scientific in this capacity in 2020. Additionally, she is a board member at Paragon 28, a position she has held since 2022.
Professional Title
Meghan Scanlon holds the title of President of the Urology Division at Boston Scientific. In this role, she is responsible for leading the division’s strategic initiatives and overseeing its overall operations.
Background
Meghan Scanlon has a diversified background in the medical device and engineering fields. She began her career as a Mechanical Engineer at Altitude from 1993 to 1995 before moving to The Gillette Company, where she worked as a Product Engineer from 1995 to 1998. Her background also includes significant leadership roles at Johnson & Johnson and DePuy Synthes - Mitek Sports Medicine, focusing on marketing, strategic planning, and platform development.
Education and Expertise
Meghan Scanlon has a solid educational foundation in engineering and management. She holds a Bachelor of Science in Mechanical Engineering (BSME) from Tufts University (1991-1995). She furthered her education at the Massachusetts Institute of Technology (MIT), where she earned a Master of Science in Mechanical Engineering (MSME) and an MBA from the MIT Sloan School of Management, both from 1998 to 2000.
Achievements
During her tenure at Boston Scientific, Meghan Scanlon has been instrumental in talent development and portfolio innovation. She has driven significant advancements in commercial execution within the medical device industry. Additionally, she serves as the Executive Sponsor for the PRIDE Employee Resource Group at Boston Scientific, promoting diversity and inclusion within the company.